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Priapism Treated With Penile Cavernosal-Dorsal
Vein Shunt Using Saphenous Vein Graft
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and Fleur L. Broughton
OBJECTIVES
METHODS

RESULTS

CONCLUSIONS

To assess the outcome of new penile cavernosal-dorsal vein shunt using a saphenous vein graft.
Traditional surgeries for priapism have high failure rate and subsequent impotence.
We reviewed the medical records of, and administered a questionnaire and the International
Index of Erectile Function to, 16 consecutive patients with priapism who had treated with the
penile cavernosal-dorsal vein shunt from 1997 to 2007. Their age was 15-65 years. The duration
of ischemic priapism was 32 hours to 8 days. Ten patients had previously undergone shunt surgery
by other urologists. Of the 16 patients, 5 returned the questionnaires.
Priapism resolved or was improved after surgery in all 16 patients. One patient was lost to
follow-up. One pediatric patient was excluded from the analysis. One patient with nonischemic
priapism continued to have sexual intercourse. Of the 13 adult patients with ischemic priapism
and follow-up for ⱕ6.5 years, 3 patients had no erection, 1 had very little erection, and 9 (69%)
had erection. Of the 9 patients with erections possible, six had had sexual intercourse (International Index of Erectile Function score 32-70) and 3 had not; 1 had a mental disorder, 1 was
in prison, and for 1, the reason was unknown. After surgery, color Doppler ultrasound studies
showed a patent shunt in all patients and restoration of cavernosal arterial flow in 12 of 13
patients studied.
A penile cavernosal-dorsal shunt appears effective for priapism. It resulted in priapism resolution
even in patients who had experienced a previous failed cavernosal-glandular shunt or cavernosalspongiosal shunt, with a high rate of sexual function preservation. UROLOGY 73: 556 –561,
2009. © 2009 Elsevier Inc.

riapism is a urologic emergency. It is traditionally
divided into ischemic (low-flow) and nonischemic
(high-flow) priapism, with each requiring different
management strategies. The management goal of ischemic priapism is to achieve detumescence and preserve as
much erectile function as possible. The initial treatment
for ischemic priapism is usually aspiration and intracavernous injection of sympathomimetic drugs with or without irrigation. If this fails to resolve the priapism, some
form of cavernosal-glandular shunt (Winter or AlGhorab shunt) is commonly performed. Proximal shunting procedures using the Quackels (cavernosal-spongiosal)
or Grayhack (cavernosal-saphenous vein) technique are per-

P

formed when distal shunting procedures have failed to
resolve the priapism. The efficacy of shunting procedures
in resolving priapism and the outcome of preserving
erectile function have varied among reports. Some investigators have reported very disappointing outcomes using
commonly performed shunting procedures.1 We have
previously reported on a new surgical technique involving the saphenous vein graft and the penile cavernosaldorsal vein (CD) shunt.2,3 In the present study, we have
reviewed our clinical experience of treating 16 patients
with priapism using this new shunt procedure and examined the sexual function outcome of these patients.
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MATERIAL AND METHODS
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We performed a retrospective chart review of 16 consecutive
patients with priapism who were treated with a penile CD shunt
from July 1997 to December 2007 (Table 1). In addition to
documenting the review, we administered by mail the Interna-
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Table 1. Patient characteristics
Duration
Before CD
Shunt

Pt.
No.

Age
(y)

1

45

Idiopathic

32 h

Asp/IPT, Winter
shunt

2

45

Idiopathic

2d

3

31

Idiopathic

2d

Asp/IPT, Winter
shunt
Asp/IPT

4

15

3d

Asp/IPT

5

65

Sickle
cell disease
Idiopathic

3d

Asp/IPT

6

30

Idiopathic

3d

Asp/IPT, AlGhorab shunt

7

57

Trazodone

3d

8

49

Idiopathic

4d

Asp/IPT, Winter
shunt
Asp/IPT, Winter
shunt

9

36

4d

10

44

Chronic myeloid
leukemia
Idiopathic

11

36

Idiopathic

5d

12

48

Trazodone

6d

13

41

6d

14

25

15

25

Psychiatric
medication
Chronic renal
failure
Idiopathic

16

33

Trauma

3 wk

Cause

4.5 d

1 wk
8d

Previous
Treatment

Asp/IPT, AlGhorab shunt
Asp/IPT, Winter
shunt
Asp/IPT,
Winter,
Quackel
shunts
Asp/IPT, Winter
shunt
Asp/IPT
Asp/IPT, Winter
shunt
Sudafed
Terbutaline,
Asp/IPT

Outcome After CD Shunt
Priapism resolved, has erection,
sex, IIEF score 60 (Q1-5, Q25, Q3-5, Q4-5, Q5-5*)
Priapism resolved, induration
present, little erection, no sex
Priapism resolved, mental
retardation, erection, no sex
Priapism resolved

Follow-up
1y
4 mo
3 y, 9 mo
5 mo

Priapism resolved, patient in
prison, erection, no sex
Priapism resolved, erection,
sex, IIEF score 70 (Q1-5,
Q2-5, Q3-5, Q4-5, Q5-5)
Priapism resolved, no erection

14 mo

Priapism resolved, erection, sex
using constriction band, IIEF
score 63 (Q1-4, Q2-4, Q3-4,
Q4-4, Q5-4)
Priapism resolved

6 y, 5 mo

Priapism improved, erection,
uses Viagra for sex, IIEF
score 35 (Q1-5, Q2-1, Q3-1,
Q4-1, Q5-1)
Priapism resolved, erection,
sex, IIEF score 32 (Q1-1,
Q2-1, Q3-1, Q4-1, Q5-1)

10 mo

Priapism resolved, no erection

1 y, 4 mo

3 mo
3 mo

Lost

1y

Priapism resolved, erection,
sex, difficultly penetrating
Priapism resolved, no erection

7 mo

Priapism resolved, erection, had
not yet attempted sex
Arteriogenic priapism resolved,
potent, sex, arteriosinusoidal
malformation closed after 7 y

3 mo

1 mo

7.5 y

CD, cavernosal-dorsal vein; Asp/IPT, aspiration and intracavernosal pharmacotherapy therapy; IIEF, International Index of Erectile
Function; Q, question.
* Erection-related IIEF questions. Q1, how often were you able to get an erection during sexual activity; Q2, when you had erections with
sexual stimulation, how often were your erections hard enough for penetration; Q3, when you attempted sexual intercourse, how often
were you able to penetrate (enter) your partner; Q4, during sexual intercourse, how often were you able to maintain your erection after you
had penetrated (entered) your partner; Q5, during sexual intercourse, how difficult was it to maintain your erection to completion of
intercourse (each with scale of 0-5).

tional Index of Erectile Function and a questionnaire assessing
the degree of spontaneous erection, information about supplemental measures to obtain or enhance erection, recurrent episodes of priapism, and more necessary surgical procedures.4 All
saphenous vein graft penile CD shunt procedures were performed by an experienced urologist (R.K.C.). The age of patients was 15-65 years. One patient was a boy with sickle cell
disease. The age of the adult patients was 21-65 years. The
causes of priapism were idiopathic in 9 patients, antidepressant
or other psychiatric medication in 3 patients, and trauma, sickle
cell disease, chronic myeloblastic leukemia, and chronic renal
failure in 1 patient each. One patient had developed traumatic
high-flow priapism of 3 weeks’ duration before surgery, and the
other 15 patients had had ischemic priapism for 32 hours to 8
UROLOGY 73 (3), 2009

days (mean duration 4.1 days). In the 15 patients with ischemic
priapism, previous treatment consisting of aspiration with intracavernosal pharmacotherapy had failed. Ten patients were
initially treated by other urologists with common surgical interventions before they were referred to us. Of these 10 patients,
9 had a failed cavernosal-glandular (Winter or Al-Ghorab)
shunt and 1 had a failed Winter shunt and cavernosal-spongiosal (Quackels) shunt.
Color Doppler ultrasound (CDU) studies were performed in
the 15 patients before penile CD shunt surgery. With the penis
gently placed toward the abdomen, and the transducer placed at
the ventral surface of the penis, we examined the cavernosal
arterial blood flow of the proximal and mid-penile shafts and
measured the hemodynamic parameters, including the peak
557

Figure 1. Penile cavernosal-dorsal vein shunt using saphenous vein graft. Upper end of saphenous vein graft anastomosed to deep dorsal vein.
systolic velocity (PSV), end-diastolic velocity, and resistive
index.5 In patients with perineal trauma, we also placed the
transducer at the perineum to examine the cavernosal arteries
at the crura. After surgery, 20 CDU studies were completed in
13 patients.
The surgical technique of the penile CD shunt has been
previously described.2,3 In brief, an oblique incision was made at
the base of the penis to identify the dorsal vein and expose the
corpora. A 2.5-3– cm segment of the saphenous vein was then
harvested from the lower leg, and an anastomosis was created
with the cephalad end of the saphenous vein graft connecting
to the dorsal vein and the caudal end connecting to a proximal
corporal window using 4-0 or 5-0 Prolene suture (Fig. 1 and Fig. 2).

RESULTS
In all 16 patients, the priapism resolved or was improved
after penile CD shunt placement. No additional procedures were required in these patients. The CDU studies,
before penile CD shunt surgery, showed no detectible
cavernosal arterial flow at the proximal penile shaft in 13
of 15 patients studied. This indicated that their previous
therapeutic interventions had not relieved the venoocclusive mechanism. In 1 patient, cavernosal arterial
flow was present, but it appeared to stop at the area of the
proximal to mid-penile shaft junction. In this patient, we
noted an arterial branch from the proximal corpus cavernosum to the corpus spongiosum. This anatomic variation might have been responsible for maintenance of
the blood flow at the proximal penile shaft. In 1 patient,
who developed priapism after perineal trauma, the CDU
study showed an arteriosinusoidal malformation at the
crura, with a high PSV of 30.9 cm/s, indicating an arteriogenic origin of the priapism. The CDU studies after
surgery showed the presence of blood flow in the CD
shunt, indicating its patency in all 13 patients studied.
Relief of the veno-occlusive status and restoration of the
cavernosal arterial blood flow were observed in 12 of the
13 patients studied. The postoperative cavernosal arterial
PSV varied among patients. One patient had resolution
558

Figure 2. Completion of penile cavernosal-dorsal vein
shunt with lower end of saphenous vein graft anastomosed
to corpora window.

of priapism and transient cavernosal arterial flow restoration; however, subsequent CDU studies showed no
detectible cavernosal arterial blood flow despite the presence of a patent shunt. Some patients appeared to have
postischemic hyperemia, with a PSV of ⱕ27.3 cm/s (see
Table 2). In 1 patient with arteriogenic priapism, the
CDU studies, after placement of a penile CD shunt,
showed improvement in priapism hemodynamics, with
persistence of the arteriosinusoidal malformation during
short-term follow-up. After 7.5 years, at the long-term
follow-up examination, spontaneous closure of the arteriosinusoidal malformation was noted on the CDU study.
One patient did not return to the clinic for follow-up
after discharge and also did not return the questionnaires.
The other 15 patients had been followed up after penile
CD shunt surgery, with follow-up of 1 month to 7.5 years.
One pediatric patient was excluded from the sexual function outcome analysis. Of the 13 adult patients with
low-flow priapism, 3 indicated a complete lack of erections during follow-up and 1 had very little erection. The
other 9 patients (69%) reported having spontaneous
erections after penile CD shunt surgery. Of the 9 patients
with erections, 6 had sexual intercourse after surgery. Of
these 6 patients, 3 had an International Index of Erectile
Function score of ⱖ60 and 2 had a score of ⱕ35 (Table
1). The last patient did not provide an International
Index of Erectile Function score but indicated that he
UROLOGY 73 (3), 2009

Table 2. Outcomes
CDU Before CD Shunt
PSV (cm/s)
EDV (cm/s)

Pt.
No.
1
2

No flow
No flow

No flow
No flow

CDU After CD Shunt
EDV (cm/s)

RI

PSV (cm/s)

—
—

20.1 (1 h), shunt patent
8.29 (1 h), shunt patent
No flow (1 d), shunt patent
No flow (3 d), shunt patent
20.0 (2 d), shunt patent
3.57 (11 d), shunt patent
7.55 (10 d), shunt patent
21.3 (2 d), shunt patent
7.0 (1 mo), shunt patent
3.0 (1 d), shunt patent
Flow present, PSV not measured
(3 wk), shunt patent
7.0 (15 d), shunt patent
—
No flow (3 d), shunt patent
27.3 (4 d), shunt patent
—
Flow present, PSV not measured
(1 h), shunt patent

3
4
5
6

No
No
No
No

flow
flow
flow
flow

No flow
No flow
No flow
No flow

—
—
—
—

7

No flow

No flow

—

8
9
10
11
12
13

11.0
No flow
—
No flow
No flow
No flow

⫺2.0
No flow
—
No flow
No flow
No flow

1.2
—
—
—
—
—

14
15

No flow
No flow

No flow
No flow

—
—

16

30.9, prominent
arteriosinusoidal
malformation

⫺3.69

—
10.3 (1 d), shunt patent
6.04 (9 d), shunt patent
1.12 13.6 (40 d), shunt patent,
persistent arteriosinusoidal
malformation
13.8 (3 mo), shunt patent
persistent arteriosinusoidal
malformation
15 (7.5 y), n flow in shunt, no
arteriosinusoidal malformation

0.0
⫺2.13
No flow
No flow
5.0
0.0
2.61
5.32
0.0
—
—

RI
1.0
1.26
No flow
No flow
0.7
1.0
0.65
0.75
1.0
—
—

1.22
—
No flow (3 d), shunt patent
3.19
—
Flow present, PSV not
measured (1 h), shunt
patent
—
2.33
3.02
4.03

0.8
—
—
0.88
—
—

⫺2.98

1.22

0.0

1.0

—
0.8
0.5
0.7

CDU, color Doppler ultrasonography; PSV, peak systolic velocity; EDV, end-diastolic velocity; RI, resistive index; other abbreviations as in
Table 1.

had sexual intercourse with only a partial erection and
difficulty penetrating. One patient indicated satisfactory sexual function but needed to use a constriction
band periodically. Another patient used Viagra. Finally, 3 of the 9 patients with erections did not have
sexual intercourse. Of these 3 patients, 1 indicated
having good erections, but was in prison and could not
engage in sexual intercourse. Another patient experienced spontaneous erections but was mentally retarded
and did not engage in sexual activity. Another patient
had erections, but he did not try to have sexual intercourse for unknown reasons. All 4 patients who had
high cavernosal arterial flow (PSV ⱖ20 cm/s) after
surgery had erections during follow-up, despite the
duration of priapism (ⱕ8 days; Tables 1 and 2).
One patient with perineal trauma-related high flow
(arteriogenic) priapism continued to have periodic erections after surgery. He indicated that the periodic erections were much less troublesome then before surgery,
and he was able to have sexual intercourse for ⬎7 years
after penile CD shunt placement. He developed erectile
dysfunction a few months before his 7.5-year follow-up
visit. The timing of the erectile dysfunction appeared to
correlate with the spontaneous closure of the arteriosinusoidal malformation.
UROLOGY 73 (3), 2009

COMMENT
Ischemic priapism is a urologic emergency that requires
prompt diagnosis and effective treatment. Stagnant blood
in the corpora leads to deprivation of oxygen and an
increase in carbon dioxide, which causes erectile tissue
dysfunction, thrombosis, and, eventually, fibrosis of the
erectile tissues, resulting in erectile dysfunction.6 Evacuation of the trapped blood by providing effective drainage
of the corpora and restoring cavernosal blood flow are
important to the preservation of erectile function. Although many patients with priapism of a relative short
duration can be successfully treated with penile aspiration and intracavernosal pharmacotherapy using sympathomimetic drugs, patients who do not respond to such
treatment usually require some type of shunting procedure to divert the corporeal blood. Lue and Tanagho
et al.7 recommended that priapism of ⬍24 hours’ duration be treated with aspiration or intracorporeal pharmacotherapy and priapism lasting ⬎24 hours be treated with
a shunting procedure.
Various shunting procedures have been described. Although it is a common practice to use a Winter shunt or
another modified cavernosal-glandular shunt for the initial treatment of priapism in patients who have not
559

responded to penile aspiration and intracavernosal pharmacotherapy, Nixon et al.1 reported that 86% of their
patients treated with a Winter shunt required a second
shunt procedure. This seriously questions the effectiveness of a Winter shunt.1 Lue and Pescatori8 described a
T-shunt as a new form of cavernosal-glandular shunt.
The potency outcome of patients treated with this technique is still not clear. Grayhack et al.9 described a
corpus-saphenous vein shunt as connecting the caudal
end of the dissected saphenous vein to the corpus cavernosum. Even though subsequent reports have indicated
that this approach is effective in relieving priapism, cases
of pulmonary embolism have been reported. This probably resulted from thrombosis of the shunt extending into
the saphenofemoral junction, which caused deep femoral
thrombosis.10
We have previously described our technique of a penile CD shunt. Instead of dissecting the saphenous vein
at the thigh, we use a segment of the saphenous vein at
the ankle as a free graft to create a shunt from the
proximal corpora to the dorsal vein of the penis. The
harvest of the saphenous vein at the ankle is simple and
requires only a small incision (2-2.5 cm). Furthermore,
the creation of the penile CD shunt requires only a small
(2.5-cm) incision at the base of penis. The advantages of
the penile CD shunt, compared with the Grayhack procedure, include a short and more direct course of drainage
to the pelvic veins, easy dissection of the saphenous vein
at the ankle, and smaller incisions. Compared with the
cavernosal-spongiosal (Quackels) shunt, the penile CD
shunt has the advantage of not requiring urethral dissection, avoiding the potential problem of causing the development of a urethrocavernous fistula or urethral stricture.11,12 In addition, the penile CD vein shunt can be
easily accessed for ligation, if necessary. In contrast, the
cavernosal-spongiosal (Quackels) shunt is not amenable
to surgical closure.
In our experience, several patients in whom an initial
cavernosal-glandular shunt procedure failed will respond
well to the penile CD shunt. This outcome is likely
because although thrombosis of the distal corpora had
occurred, adequate blood flow and viable cavernosal tissue were still present at the proximal corpora. In 1
patient, we noted improvement in the priapism and resolution of pain with placement of a penile CD shunt after
a failed proximal cavernosal-spongiosal shunt. We believe this might have resulted from the advantage of a
larger caliber of saphenous vein drainage with the CD
shunt. Conversely, spongiosal tissue might be more susceptible to thrombosis.
The selection of an appropriate shunting procedure
might have an affect on the preservation of erectile
capacity. If we find clinical indications for distal corporal
fibrosis, we do not use the cavernosal-glandular (Winter/
Al-Ghorab) shunts. For example, if we observed at penile
aspiration that the proximal penile shaft became soft but
the distal penile shaft remained hard, it would be likely
560

that the distal corpora had thrombosed and it would had
been more appropriate to proceed with a proximal shunt
rather than to perform a cavernosal-glandular shunt for
these patients. Both the proximal and distal penile shaft
shunts are designed to drain the blood for the whole
cavernosal body. However, the shunt created at the
thrombosed portion probably could not effectively drain
the blood from other portions of the corpus cavernosum.
We have determined that using CDU for various stages
of the management of priapism is effective. The value of
CDU in distinguishing between ischemic and nonischemic priapism is also well recognized. In addition, CDU
is useful for checking the patency of the shunt and
assessing the hemodynamics to confirm the effective relief of veno-occlusive status. This is particularly important when the clinical resolution of priapism is not complete. The lack of complete resolution of priapism could
be related to thrombosis of the cavernosal tissue, cavernosal hyperperfusion status after successful shunt surgery,
or inadequate drainage of a shunt. With successful shunt
surgery, we usually observe the restoration of cavernosal
arterial flow. It is also useful for assessing the patency of
the CD shunt after surgery. In 1 patient, the postoperative CDU showed no detectible blood flow; however, his
CD shunt was patent. We believe that this lack of blood
flow was due to cavernosal tissue damage rather than
persistence of veno-occlusive pathophysiologic features.
Thus, we did not perform additional surgery. It is difficult
to check the patency of the cavernosal-glandular (Winter/Al-Ghorab) and cavernosal-spongiosal (Quackels)
shunts using CDU.5
The potency outcome after shunt surgery has varied
among reports. Nixon et al.1 reported that only 2 of 20
patients (10%) with available follow-up had complete
preservation of erectile function after shunt surgery.
Three men (15%) reported partial erection and 15 (75%)
had no erection at follow-up.1 In our series, even though
previous shunt surgery by other urologists in many patients had failed, we observed an encouraging outcome of
69% of the patients having spontaneous erections after
penile CD shunt surgery. We believe that the widecaliber nature of the penile cavernosal-dorsal vein shunt
using a saphenous vein graft might have contributed to
the encouraging results. Furthermore, postoperative hyperemia might function as a repair mechanism for ischemic damage. Patients with a high cavernosal blood flow
(PSV ⱖ20 cm/s) appeared to have good potency outcomes despite their duration of priapism, which lasted as
long as 8 days.
This series included 1 patient with high-flow priapism
resulting from perineal trauma. Shunt surgery is not a
standard treatment option for high-flow priapism. However, this patient elected to undergo this procedure as an
alternative treatment of cavernosal artery embolization,
which has a risk of erectile dysfunction. After shunt
surgery, he remained potent and sexually active for ⬎7
years and had spontaneous closure of his arteriosinusoidal
UROLOGY 73 (3), 2009

malformation about 7-7.5 years after surgery. At last
follow-up, he required oral medication for his erectile
dysfunction.

CONCLUSIONS
The penile CD shunt is effective in relieving priapism
and has an encouraging rate of preservation for subsequent spontaneous erections. The advantages of this
technique include wide and direct drainage of the corpora to pelvic veins, no risk of urethral complications,
easy CDU assessment of shunt patency after surgery and
femoral vein thrombosis, and easy access for constriction
band compression or surgical ligation. In our experience,
it appears to be effective in treating many patients with
persistent priapism even after cavernosal-glandular or
cavernosal-spongiosal shunts have failed.
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